File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation

TitleALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation
Authors
Issue Date2020
PublisherWiley Open Access. The Journal's web site is located at http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2471-254X/
Citation
Hepatology Communications, 2020, v. 4 n. 11, p. 1624-1636 How to Cite?
AbstractThe current alanine aminotransferase (ALT) upper limit of normal was defined using selected healthy Caucasian blood donors. Given the global rise in obesity and different body habitus in Asians, we aimed to perform a systematic review and meta-analysis combined with bootstrap modeling and individual patient data validation to estimate the ALT upper threshold for Asians, including the overweight and diabetics. We included studies from PubMed, Embase, and Cochrane database searches that identified individuals without known liver diseases (i.e., viral hepatitis, alcohol, and ultrasound-detected nonalcoholic fatty liver disease). The mean ALT (U/L) was estimated using a random-effects mixed model and upper threshold (95th-percentile value, U/L) via a bootstrap model with 10,000 resamples. We screened 4,995 studies and identified 86 studies that reported ALT values for 526,641 individuals without excessive alcohol intake or known liver diseases, yielding a mean ALT of 19 and ALT upper threshold of 32. The ALT upper threshold was 37 in males versus 31 in females, 39 in overweight versus 28 in normal-weight individuals, and 36 for diabetics versus 33 for nondiabetics. We validated our study level data with individual patient level data in 6,058 individuals from five study centers in Japan. Consistent with our study-level data, we found that the ALT upper threshold in our individual patient data analysis was indeed higher in overweight versus normal-weight individuals (39 vs. 32) and in diabetics versus nondiabetics (42 vs. 33). Conclusion: We provide validated reference ranges for ALT upper threshold derived from Asians without known liver disease, including individuals with ultrasound-detected nonalcoholic fatty liver disease who are normal weight, overweight, nondiabetic, and diabetic, to inform practice.
Persistent Identifierhttp://hdl.handle.net/10722/304263
ISSN
2023 Impact Factor: 5.6
2023 SCImago Journal Rankings: 2.217
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHuang, DQ-
dc.contributor.authorYeo, YH-
dc.contributor.authorTan, E-
dc.contributor.authorTakahashi, H-
dc.contributor.authorYasuda, S-
dc.contributor.authorSaruwatari, J-
dc.contributor.authorTanaka, K-
dc.contributor.authorOniki, K-
dc.contributor.authorKam, LY-
dc.contributor.authorMuthiah, MD-
dc.contributor.authorHyogo, H-
dc.contributor.authorOno, M-
dc.contributor.authorBarnett, SD-
dc.contributor.authorLi, J-
dc.contributor.authorZou, B-
dc.contributor.authorFung, J-
dc.contributor.authorLee, TY-
dc.contributor.authorWong, VWS-
dc.contributor.authorYuen, MF-
dc.contributor.authorDan, YY-
dc.contributor.authorLim, SG-
dc.contributor.authorCheung, R-
dc.contributor.authorToyoda, H-
dc.contributor.authorEguchi, Y-
dc.contributor.authorNguyen, MH-
dc.date.accessioned2021-09-23T08:57:33Z-
dc.date.available2021-09-23T08:57:33Z-
dc.date.issued2020-
dc.identifier.citationHepatology Communications, 2020, v. 4 n. 11, p. 1624-1636-
dc.identifier.issn2471-254X-
dc.identifier.urihttp://hdl.handle.net/10722/304263-
dc.description.abstractThe current alanine aminotransferase (ALT) upper limit of normal was defined using selected healthy Caucasian blood donors. Given the global rise in obesity and different body habitus in Asians, we aimed to perform a systematic review and meta-analysis combined with bootstrap modeling and individual patient data validation to estimate the ALT upper threshold for Asians, including the overweight and diabetics. We included studies from PubMed, Embase, and Cochrane database searches that identified individuals without known liver diseases (i.e., viral hepatitis, alcohol, and ultrasound-detected nonalcoholic fatty liver disease). The mean ALT (U/L) was estimated using a random-effects mixed model and upper threshold (95th-percentile value, U/L) via a bootstrap model with 10,000 resamples. We screened 4,995 studies and identified 86 studies that reported ALT values for 526,641 individuals without excessive alcohol intake or known liver diseases, yielding a mean ALT of 19 and ALT upper threshold of 32. The ALT upper threshold was 37 in males versus 31 in females, 39 in overweight versus 28 in normal-weight individuals, and 36 for diabetics versus 33 for nondiabetics. We validated our study level data with individual patient level data in 6,058 individuals from five study centers in Japan. Consistent with our study-level data, we found that the ALT upper threshold in our individual patient data analysis was indeed higher in overweight versus normal-weight individuals (39 vs. 32) and in diabetics versus nondiabetics (42 vs. 33). Conclusion: We provide validated reference ranges for ALT upper threshold derived from Asians without known liver disease, including individuals with ultrasound-detected nonalcoholic fatty liver disease who are normal weight, overweight, nondiabetic, and diabetic, to inform practice.-
dc.languageeng-
dc.publisherWiley Open Access. The Journal's web site is located at http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2471-254X/-
dc.relation.ispartofHepatology Communications-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation-
dc.typeArticle-
dc.identifier.emailFung, J: jfung@hkucc.hku.hk-
dc.identifier.emailYuen, MF: mfyuen@hku.hk-
dc.identifier.authorityFung, J=rp00518-
dc.identifier.authorityYuen, MF=rp00479-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/hep4.1593-
dc.identifier.pmid33163833-
dc.identifier.pmcidPMC7603525-
dc.identifier.scopuseid_2-s2.0-85103979288-
dc.identifier.hkuros325491-
dc.identifier.volume4-
dc.identifier.issue11-
dc.identifier.spage1624-
dc.identifier.epage1636-
dc.identifier.isiWOS:000570299500001-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats